Bio-Rad Laboratories (BIO) Shares Outstanding (2009 - 2026)

Bio-Rad Laboratories (BIO) has 18 years of Shares Outstanding (Entity) data on file, last reported at $27.0 million in Q1 2026.

• On a quarterly basis, Shares Outstanding (Entity) fell 3.52% year-over-year to $27.0 million in Q1 2026; TTM through Mar 2026 was $27.0 million, a 3.52% decrease from a year earlier, with the FY2025 full-year figure at $27.3 million, down 3.37% from the prior year.
• Shares Outstanding (Entity) for Q1 2026 stood at $27.0 million, down from $27.3 million in the prior quarter.
• Over the last five years, Shares Outstanding (Entity) for BIO reached as high as $29.9 million in Q1 2022 and fell as low as $26.9 million in Q3 2025.
• Historically, Shares Outstanding (Entity) has averaged $28.6 million across 5 years, with a median of $28.5 million in 2024.
• Across the five-year window, Shares Outstanding (Entity) gained 0.37% in 2022 and dropped 4.12% in 2025, its largest moves.
• Year by year, Shares Outstanding (Entity) stood at $29.8 million in 2022, then dropped by 1.93% to $29.2 million in 2023, then dropped by 3.41% to $28.2 million in 2024, then decreased by 3.37% to $27.3 million in 2025, then decreased by 1.12% to $27.0 million in 2026.
• Per Business Quant data, the three most recent Shares Outstanding (Entity) figures were $27.0 million in Q1 2026, $27.3 million in Q4 2025, and $26.9 million in Q3 2025.